BPA for daraprim
Ended Awarded Last action
- Contract number
- 36E79721A0025
- Awardee
-
Vyera Pharmaceuticals, LLC UEI DC7GXJ8ECCQ9
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $2,500.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Vyera Pharmaceuticals, LLC on October 8, 2021. The BPA utilizes the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and has a potential value of $2.5 million.
The BPA is for a single award to procure Daraprim through October 4, 2022. Daraprim is an antimalarial and antiparasitic drug used to treat toxoplasmosis. As the awarding agency, the VA National Acquisition Center likely aims to ensure an adequate and consistent supply of this medication for veterans receiving care through the VA healthcare system.
No set-asides were used in the award of this BPA, reflecting the VA's need to quickly obtain this essential pharmaceutical. Vyera Pharmaceuticals will deliver Daraprim to VA medical facilities nationwide over the one-year ordering period. The BPA establishes the terms and conditions by which the VA can issue delivery orders for Daraprim on an as-needed basis, while leveraging pre-negotiated pricing under the referenced GSA schedule.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0025?
36E79721A0025 was awarded to Vyera Pharmaceuticals, LLC by National Acquisition Center (Headquarters) on October 8, 2021.
How much is contract 36E79721A0025 worth?
36E79721A0025's own ceiling is $2,500.
Who can order from contract 36E79721A0025?
36E79721A0025 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0025 under another contract?
Yes. 36E79721A0025 is a blanket purchase agreement under V797D60711, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0025 competed?
The extent of competition for 36E79721A0025 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV